NCT06734065 Effect of Non-Invasive Lung Fluid Monitoring for Heart Failure Management in Primary Care
| NCT ID | NCT06734065 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Linkoeping University |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 330 participants |
| Start Date | 2025-04-16 |
| Primary Completion | 2030-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 330 participants in total. It began in 2025-04-16 with a primary completion date of 2030-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Remote dielectric sensing (ReDS) technology offers a non-invasive method for assessing lung congestion. This randomized controlled trial aims to evaluate the effectiveness and processes of the ReDS-guided heart failure management program in primary care settings for patients with heart failure.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years, there is no upper age limit * Diagnosed with heart failure regardless of left ventricular ejection fraction * Having New York Heart Association (NYHA) Class III/IV irrespective of prior hospitalisation for heart failure, or NYHA II with a history of at least one hospitalisation for heart failure within the previous 12 months * Elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) within 12 months: (a) ≥450 pg/ml for patients under 50 years; (b) ≥900 pg/ml for patients aged 50-75 years; (c) ≥1800 pg/ml for patients over 75 years. Exclusion Criteria: * NYHA I * Life expectancy \<6 months * Physical characteristics that prevented use of the ReDS (body mass index \< 22 or \>39, and height less than 155 cm or higher than 195 cm) * Implantation of a left ventricular assist device or cardiac transplantation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06734065 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06734065 currently recruiting?
Yes, NCT06734065 is actively recruiting participants. Contact the research team at naoko.perkio.kato@liu.se for enrollment information.
Where is the NCT06734065 trial being conducted?
This trial is being conducted at Flen, Sweden.
Who is sponsoring the NCT06734065 clinical trial?
NCT06734065 is sponsored by Linkoeping University. The trial plans to enroll 330 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.